Wire · opportunities
FDA Approves Phentolamine Eye Drop for Presbyopia in Adults
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 October 2026 · Fusion42 review
The FDA has approved phentolamine ophthalmic solution 0.75% (Ryzumvi; Viatris) for treating presbyopia in adults as a once-nightly eye drop, following positive phase 3 VEGA-2 and VEGA-3 trials demonstrating improved near vision. The approval offers a new therapeutic option for age-related near vision loss with manageable side effects and specific storage and administration guidelines.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 17 Oct 2026 and 19 Oct 2026.
◆ ◆ The Wire takeaway
Your ophthalmic product portfolio just faced new competition from a nightly eye drop that preserves distance vision while improving near focus. This shifts the presbyopia treatment market and may change patient preferences and prescribing patterns overnight.
◆ Coverage
4 sources · first reported 17 Oct 2026 · latest 19 Oct 2026
◆ Related on Wire
◆ Topics